The UK approved on Thursday the use of the anti-COVID vaccine Valneva, making it the first European country to recognize it.
The French-Austrian vaccine has a traditional inactivated virus technology, designed with messenger RNA technology.
This vaccine can also be stored at a normal temperature, which facilitates its use.
Valneva, therefore, becomes the 6th anti-COVID-19 product to be approved in the UK, after Pfizer, Moderna, J &J, Sinopharm, and Sputnik.
So far, the UK has administered at least 141,5 million doses of COVID vaccines, assuming each person needs 2 shots to have vaccinated about 105.9% of the country’s population, according to Reuters’ latest COVID tracker data released Thursday.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.